Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
261 Cards in this Set
- Front
- Back
Microsatellites |
Tandom nucleotide repeats |
|
Transposons |
Mobile DNA elements |
|
Function of transposase |
Makes cuts around donor DNA and target DNA as a part of transposon movement |
|
Robertson translocation |
Translocation in acrocentric centromeres |
|
Result of Robertson translocation |
Two chromosomes combine into one; one long arm from each and no short arm |
|
Ploidy of 47,XXX |
Aneuploid |
|
Ploidy of 92,XXXX |
Tetraploid (polyploid) |
|
Ploidy of 47,XY + 22 |
Aneuploid (trisomy of 22) |
|
Ploidy of 45, XY - 3 |
Aneuploid (monosomy of 3) |
|
46,XX/47,XXX |
Mosaic |
|
Folic acid in embryos |
Important for neural tube development |
|
Folic acid in adults |
DNA replication |
|
Use of N10-Formyl-FH4 (tetrahydrofolic acid) |
Purine synthesis |
|
First derivative of FH4 |
Tetrahydrofolic acid (N10-Formyl-FH4)
|
|
Use of N5,N10-methylene FH4 |
DNA synthesis (dUMP to dTMP) |
|
Second derivative of FH4 |
N5,N10-methylene FH4 77 |
|
Use of N5-methyl-FH4 |
Homocysteine to methionine in methionine cycle |
|
Function of B12 in the methionine cycle |
Removes methyl group from methyl-FH4 and uses it to methylate homocysteine (now methionine) |
|
Function of SAM in the methionine cycle |
SAM is a product of methionine and ATP. Donates methyl group for many reactions |
|
Function of folic acid in methionine cycle |
Derivative of folic acid donates a methyl group so homocysteine can be converted to methionine |
|
First step of purine synthesis |
Start with PRPP, then assemble the purine base |
|
Second step of purine synthesis |
Rate limiting step; amine group is added |
|
Third step of purine synthesis |
IMP separates into 2 branches that end with GTP and ATP |
|
Regulation of purine |
Feedback inhibition |
|
Allosteric inhibitor |
Inhibitor binds at site that is different from the substrate binding site |
|
FirsPyramidine synthesis |
Pyrimidine ring is synthesized, then ribose is attached |
|
Function of methotrexate |
Blocks conversion of folate into FH4 (blocks DNA synthesis) |
|
Initiation of DNA replication |
Helicase is recruited to ORI by ORC, then unwinds DNA |
|
Elongation in DNA replication |
Leading primer synthesis, unwinding, lagging primer synthesis |
|
Termination in DNA replication |
Strand ligation |
|
DNA Pol Alpha |
Finished making primer after RNA primase |
|
DNA Pol Delta |
Synthesizes lagging strand |
|
DNA Pol Epsilon |
Synthesizes leading strand |
|
What clamps DNA Pol to the DNA |
PCNA |
|
Function of Replication Protein A (RPA) |
Binds to ssDNA to maintain uniform conformation |
|
What binds to ssDNA at the replication for to ensure it doesn't aggregate |
Replication Protein A (RPA) |
|
Two components that make the RNA Primer |
RNA Primase and DNA Pol Alpha |
|
What opens PCNA |
RFC |
|
Function of PCNA |
Clamps DNA pol to DNA |
|
Function of RNAase |
Removed primer |
|
Function of telomerase |
Adds Tel sequence to end of the lagging strand after the primer is removed (ensures that strand does not shorten) |
|
Type I Topoisomerase |
Nicks one strand, then rejoins them |
|
Blocks Type I Topoisomerase |
Camptothecins |
|
Function of Camptothecins |
Blocks Type I Topoisomerase |
|
Type II Topoisomerase |
Nicks both strands of DNA, then rejoins them |
|
Blocks Type II Topoisomerase |
Quinolones and fluoroquinolones |
|
Function of quinolones and fluoroquinolones |
Blocks Type II Topoisomerase |
|
Tautomerism |
Balance between keto and enol form (allows for atypical base pairing) |
|
Depurination |
No base to pair with |
|
Deamination |
Causes bases to mispair |
|
What type of damage does ATM regulate |
dsDNA breaks |
|
What type of damage does ATR regulate |
dsDNA breaks, stalled replication forks, DNA mismatches, and nucleotide damage |
|
Function of p21 |
Arrests cells in G1 phase |
|
Function of Cdc25 |
Arrests cells in G2 phase |
|
What does p53 (Tumor Supressor gene regulate) |
Apoptosis and activation of p21 |
|
What does direct reversal repair |
Reversible DNA damage, like alkylation |
|
Function of MGMT |
Involved in direct reversal repair; removes alkylation from DNA |
|
What does base excision repair |
Incorrect base pairing |
|
How does base excision repair work |
Base is removed by DNA Glycosylase. Endonuclease cuts back bone, lyase cuts other side. |
|
What does nucleotide excision repair |
Thymine-thymine dimers |
|
Process of nucleotide excision repair |
TFIIH opens DNA helix, endonucleases cleave the dimer, then the gap is repaired |
|
What does mismatch repair do |
Repairs error in the daughter strand |
|
Process of mismatch repair |
MSH6 recognized mutation, MSH2 stabilizes the binding. Helicase unwinds, endonuclease cleaves |
|
What mutation is linked to HNPCC (Lynch's Syndrome) |
Mutations in MSH2 and MLH1 (mismatch repair) |
|
What mutation is linked to xeroderma pigmentosum |
Nucleotide excision repair process |
|
What mutation is linked to BRCA-I Associated Breast Cancer |
Double strand break reapair (BRCA I produces tumor supressor proteins) |
|
Cause of double strand break |
Ionizing radiation |
|
Two methods the repair double strand breaks |
Non-homologous end joining (NHEJ) and Homologous recombination |
|
Class I trinucleotide repeat disorders: Caused by |
Expansion of noncoding repeats |
|
Class I trinucleotide repeat disorders: Results in
|
Loss of protein expression |
|
Class II trinucleotide repeat disorders: Caused by:
|
Expansion of noncoding repeats |
|
Class II trinucleotide repeat disorders: Results in: |
Novel properties on the RNA |
|
Class III trinucleotide repeat disorders: Caused by: |
Expansion of codon |
|
Class III trinucleotide repeat disorders: Results in
|
Novel properties on the affected protein |
|
Anticipation |
Disease develops at earlier age and is more severe each generation |
|
Cause of anticipation |
Expansion of trinucleotide repeats (greater the expansion, greater the severity) |
|
Parental transmission bias |
Anticipation only occurs when the mutant allele is transmitted by a specific parent |
|
Fragile X Syndrome Class |
Class I |
|
Transmission of Fragile X Syndrome |
X-linked dominant |
|
Sx of Fragile X Syndrome |
Mental retardation, large/protruding ears, large testicles |
|
Mental retardation, large/protruding ears, and large testicles indicate:
|
Fragile X Syndrome |
|
Myotonic Dystrophy class |
Class 2 |
|
Transmission of Myotonic Dystrophy |
Autosomal dominant |
|
Sx of myotonic dystrophy |
Progressive muscle weakness/wasting and cataracts |
|
Progressive muscle weakness/wasting and cataracts indicate:
|
Myotonic Dystrophy |
|
Class of Huntington disease |
Class 3 |
|
Huntington Disease transmission |
Autosomal dominant |
|
Huntington Disease sx |
Neurodegeneration, and uncoordinated, jerky body movements |
|
Neurodegeneration, and uncoordinated, jerky body movements indicate
|
Huntington Disease |
|
Function of PCR |
Amplifies DNA fragment |
|
Advantages of PCR |
Fast and simple |
|
Disadvantages of PCR |
Stutter bands |
|
Stutter bands |
Other repeats are cut that are not the repeat/section of interest |
|
Southern blot |
Restriction enzyme cuts DNA at specific sites, but cannot cut if the site is methylated |
|
Initiation of transcription |
Pol binds to core promoter in dsDNA (closed complex). It melts dsDNA near the start site, forming a bubble (open complex) |
|
Elongation of transcription |
Pol advances 3'->5' down the template strand, melting dsDNA and adding rNTPs to the RNA strand |
|
Termination of transcription |
Pol releases completed RNA and dissociates from DNA once it hits the stop codon |
|
Phosphorylation of C-terminal does what |
Activates transcription |
|
Function of 5' capping |
Stabilizes mRNA, nuclear export, and translation initiation |
|
Function of poly-A tail |
Essential for RNA export to the cytoplasm |
|
Splicesome |
Complex of proteins that binds to the mRNA strand to remove introns and reconnect exons |
|
Mediators |
Protein complexes that help anchor RNA Pol II; acts as a bridge between TF and basal TFs |
|
What do mediators determine |
When and where a target gene is expressed |
|
Four DNA-Binding domains of TFs |
Homeodomain, Leucine Zipper, Helix-Loop-Helix, and Zinc Finger |
|
Structure of homeodomain |
Helix-turn-helix (side chains stick out to allow for binding) |
|
What are activators |
Nuclear receptors that have bound to a ligand |
|
What are repressors |
Nuclear receptors with no ligand |
|
Homodimers of nuclear receptors |
Binding site flanked by inverted repeats. Inactive form is in cytoplasm |
|
Heterodimers of nuclear receptors |
Binding site flanked by direct repeats. Inactive form is in nucleus |
|
Process of imprinting |
All imprints are erased during gamete formation, genes in sperm are rewritten with paternal imprint (opposite for eggs) |
|
Prader-Wili cause |
Deletion on paternal chromosome (maternal genes are imprinted, so not expressed), results in no gene in the pt |
|
Angelman Syndrome cause |
Deletion on maternal chromosome (paternal genes are imprinted), results in no gene in the pt |
|
Molar pregnancy |
Benign tumor; egg is fertilized then develops into abnormal mass of cysts |
|
Two types of molar pregnancy |
Complete (no embryo, all egg chromosomes come from father) Partial (abnormal embryo, mother gives chromosomes, father gives 2 sets) |
|
Trisomy rescue |
Lose one chromosome by nondisjunction after fertilization |
|
Heterodisomy
|
Gametes from nondisjunction on meiosis one (one chromosome from mom and one from dad) |
|
Isodisomy |
Gametes from nondisjunction in meiosis II (two chromosomes from one parent) |
|
Uniparental disomy |
Trisomy rescue; both chromosomes are from one parent |
|
Function of eIFs in mRNA translation |
Form a complex that binds the 5' cap and 3' poly-A tail, forming a loop. Increases efficiency |
|
Contents of pre-initiation complex |
Small ribosomal subunit, eIFS, and Met-tRNA |
|
Contents of initiation complex |
Large and small ribosomal subunits, tRNA |
|
When does the pre-initiation complex become the initiation complex |
When it hits the start codon and the large subunit displaces the eIFs |
|
Chaperones |
Guide recently made protein to fold in the correct structure |
|
Silent mutation |
Aka polymorphism. Same amino acid is translated; involves 3rd position in codon |
|
Nonsense mutation |
Results in stop codon |
|
Missense mutation |
Results in amino acid change |
|
Conservative vs nonconservative missense mutations |
Conservative: mutation amino acid has same properties as wild-type |
|
Function of proteosome |
Mediates degradation by recognizing proteins with ubiquitination |
|
microRNAs |
Endogenous, noncoding, can bind many targets, inhibits translation |
|
Short interfering RNA |
Exogenous, noncoding, one siRNA binds one target, degrades mRNA |
|
Mechanism of nonsense mediated decay |
Presence of EJC indicates presence of premature stop codon |
|
Ferritin |
Binds and stores excess iron |
|
IREs |
Iron-response elements. Region in 5' UTR of mRNA that detects iron |
|
Ferritin mRNA: Low iron |
IRE binding proteins bind to IREs, blocking the ribosome from translating |
|
Ferritin mRNA: High iron |
Iron binds to IRE binding proteins. IRE-BPs are not blocking the ribosome, so translation occurs |
|
Tfr |
Transferrin receptor; picks up iron in the circulatory system that's bound to transferrin |
|
Tfr mRNA: High iron |
Translation occurs; results in degradation of TfRs |
|
Tfr mRNA: Low iron |
Translation does not occur; no degradation of TfRs |
|
Allelic heterogeneity |
Different mutation on same gene |
|
Locus heterogeneity |
Mutation occurs on different genes |
|
X-linked dominant |
Affects twice as many females, heterozygous females are usually more mildly affected |
|
X-linked recessive |
Occurs more in males. All daughters of effected males are at lease carriers |
|
Calculation for penetrance |
Number of affected/total individuals with mutation |
|
Somatic mosaicism |
May result in segmental or modified gene expression |
|
Germline mosaicism |
May result in multiple affected offspring from an unaffected parent |
|
Haploisufficiency |
Contribution from single nl allele is not enough to present disease |
|
Incomplete dominance |
Trait is more severe in homozygotes |
|
Codominance |
Both alleles in the heterozygote are expressed |
|
Loss of function mutation |
Gene product is partially or wholly inactivated |
|
Null mutation |
Form of LoF mutation; complete LoF |
|
Gain of Function mutation |
New or enhanced activity of the protein |
|
Dominant Negative |
Gene product acts antagonistically to the normal phenotype. Example of haploinsufficiency |
|
Achondroplasia pathogenesis |
Affects receptor FGFR3; growth now stops in the absence of the ligand |
|
Mutation associated with Achondroplasia |
Missense, gain-of-function mutation at G380R |
|
Transmission of Achondroplasia |
Incomplete, autosomal dominant |
|
Transmission of CF |
Autosomal recessive |
|
Pathogenesis of CF |
Affects chlorine channel (CFTR); in nl pts, salt is pumped out, so water follows (keeps mucous from getting too thick) |
|
Type of mutation in CF |
Loss of Function mutation |
|
Transmission of muscular dystrophy |
X-linked recessive
|
|
Pathogenesis of muscular dystrophy |
Mutation in dystrophin gene (usually deletion), lack of dystrophin results in lack of bridging in muscle fibers |
|
Marfan Syndrome transmission |
Autosomal dominant; dominant-negative |
|
Pathogenesis of Marfan Syndrome |
Affects FDN1 gene; defect in CT |
|
Transmission of neurofibromatosis |
Autosomal dominant, often mosaic |
|
Pathogenesis of neurofibromatosis |
Affects gene that slows down cell signaling that drives cell proliferation |
|
Transmission of osteogenesis imperfecta |
Autosomal dominant |
|
Difference between Type I and Type II OI |
Type I is mild; null mutation results in deficiency in Type I collagen |
|
Carrier frequency in autosomal recessive |
2p |
|
Disease frequency in autosomal dominant |
2p |
|
Function of transposase |
Transposons; makes blunt cuts around donor DNA and staggered around target; ligates |
|
Structure of transposon product |
D. repeat, I. repeat, transposon, I. repeat, D. repeat |
|
First step of retrotransposons |
RNA polymerase makes RNA intermediate of DNA transposon |
|
Second step of retrotransposons |
Reverse transcription to get DNA intermediate |
|
Third step of retrotransposons |
Transposase nicks target DNA, transposon is inserted |
|
Structure of LTRs |
Direct repeats |
|
Function of ORF2 |
Endonuclease and reverse transcriptase in non-LTR retrotransposons |
|
Function of ORF1 |
Encoded by non-LTR r.transposon. RNA binding, transports RNA to nucleus |
|
Non-LTR retrotransposons are flanked by: |
AT-rich regions |
|
Function of HATS |
(Histone acetyltransferases)Acetylate lysine on histone |
|
Function of HDACs |
(Histone deacetylases)Remove acetylation on histone |
|
Function of HMTs |
(Histone methyltransferases) Adds methyl groups to lysine |
|
Function of KDM |
(Histone Lysine Demethylase) removes methyl groups |
|
HP1 |
(Heterochromatin protein 1) Chromatin condensation, recruits more HP1 to bind to methyl groups in adjacent histones |
|
Function of MeCP2 |
(Methyl CpG Binding Protein 2) Recognizes methylated cytosine; recruits HDAC and HMT for transcription repression |
|
Function of Rad51 |
Role in homologous recombination during double strand break repair; binds to ssDNA and invades dsDNA |
|
Function of PAR |
(Pseudoautosomal regions) enable pairing of the X and Y chromosomes |
|
Cause of NAHR |
Repeated sequence flanking a gene lead to misalignment between chromosomes; canr esult in mutations |
|
Function of dihydrofolate reductase |
Converts folated to FH4 in 2 steps |
|
End product of purine degradation |
Uric acid |
|
Function of glutamine phosporibosyl amidotransferase |
Rate limiting step in purine sythesis: adds amine group |
|
Make NDP from NMP |
Base-specific. Nucleoside monophosphate kinase phosphorylates NMP |
|
Make NTP from NDP |
Broad specificity. Nucleoside diphosphate kinase phosphorylates NDP |
|
Function of ribonucleotide reductase |
Rate limiting in d.nucleotide synthesis. Converts ribo. diphosphate form to deoxy. diphosphate form |
|
Function of deoxycytidylate deaminase |
Converts dCMP to dUMP |
|
What converts dCMP to dUMP |
Deoxycytidylate deaminase |
|
What converts ribo. diphosphate to deoxy. diphosphate |
Ribonucleotide reductase |
|
Function of Thymidylate synthase |
Converts dUMP to dTMP |
|
What converts dUMP to dTMP |
Thymidylate synthase |
|
Regulation of ribonucleotide reductase |
ATP activates, dATP inhibits. Regulates deoxynucleotide formation |
|
Function of pancreatic nucleases |
Breaks down dietary DNA/RNA into oligonucleotides in nucleic acid catabolism |
|
Function of phosphodiesterases |
Breaks down oligonucleotide into nucleotide in nucleic acid catabolism |
|
Function of phosphatases and nucleotidases |
Converts nucleotides to nucleosides in n. acid catabolism |
|
Function of adenosine deaminase |
Converts adenosine to inosine in purine catobolism (iosine then becomes hypoxanthine) |
|
Function of xanthine oxidase |
Degrades hypoxanthine -> xanthine -> uric acid |
|
Cause of gout |
Elevated uric acid |
|
Tx of gout |
Allopurinol is a hypoxanthine analog; x. oxidase acts on it instead of hypo. Reduces uric acid |
|
Function of RNase H |
Removes primer in DNA synthesis |
|
Sanger target selection |
PCR (one exon at a time) |
|
Sanger sequencing |
No separation of molecules. Mixture of reads w/ and w/o variant. Qualitative |
|
NGS |
Molecules separated, 1 sequence is read per molecule. Quantitative |
|
Problems with NGS |
High homology, repeat expansions, large in/del, and copy number variants |
|
Comparative Genomic Hybridization (CGH) |
Pt and control DNA are fluoro labeled. Compete to attach to microarray. Scanner measures fluorescent signals |
|
Single nucleotide polymorphism (SNP) |
Two or more version of a sequence present in at least 1% of the population. Most involved replacing C with T |
|
Challenges of SNP analysis in CA |
Aneuploidy, mosaicism, intratumor heterogeneity |
|
Carrier testing |
Ppl at high risk to be carriers due to FHx |
|
Carrier screening |
Ppl with no FHx, but population risk |
|
Haplotype |
Group of alleles that are so closely linked there is unlikely to be recombination |
|
LOD score function |
Tests whether data suggests two loci are linked or not. Positive score supports linkage (3+) |
|
Calculate LOD score |
likelihood of pedigree if linked/likelihood of not linked |
|
How to find error in linkage analysis |
Map distance between polymorphism and disease gene |
|
Association |
A particular marker is found significantly more or less frequently with the disease |
|
GWAS (Genome-Wide Association Studies) |
Manhattan plot: scatter plot, if point above a certain value, then it suggests the chromosomal regions are linked to risk of the disease |
|
Use of Southern Blot |
Detects large changes in size or methylation of DNA |
|
Use of ASOs (Allele Specific Oligonucleotides) |
Detects specific, often single-base, changes. Can be used as primers for PCR or probes for hybridization |
|
Use of biochemical genetic testing |
Study the amount/activity level of proteins/metabolites. Often used in newborn screening |
|
How to diagnose PKU |
Serum Phe >20mg%, positive neonatal screen (tandem mass spec) between 1 and 7 days old |
|
PKU Treatment |
Dietary restrictions and family counseling |
|
Carrier testing in Tay-Sachs |
HexA enzymatic assay; activity markedly reduced in carriers. Most common in ashkanazi jewish, then N.A. caucasian |
|
Complications in Tay-Sachs carrier testing |
Pseudodeficiency alleles; activity is only abnormal against synthetic substrate. Mist ise molecular genetic testing |
|
Tay-Sachs diagnosis |
HexA deficiency; accumulation of lipids |
|
How does PCR detect repeats |
Variation in number of repeats results in size variation of segments |
|
Function of APEI |
Endonuclease in BER; cleaves DNA backbone |
|
Function of MLH1/PMS2 |
Endonuclease in MMR |
|
Function of Ku70/80 |
Recognizes broken ends in NHEJ; acts as scaffold for other proteins |
|
First step of ssHR |
When replication for collapses, exonuclease acts on broken end |
|
Second step of ssHR |
RecA mediated strand invasion, followed by Holliday structure formation |
|
Relation of FMR1 and Fragile X Syndrome |
Encodes FMRP (protein important for mRNA transport). Transcription is blocked by methylation in Fragile X |
|
Pathogenesis of myotonic dystrophy |
Class 2 disorder. Sequesters proteins used for splicing |
|
Function of core/basal promoter |
Put RNA Pol II on transcription start site |
|
Function of RNPs |
(Ribonucleoprotein particles) prevent secondary structure formation, RNA splicing, and mRNA transport. Bind to pre-mRNA |
|
Function of snRNAs |
Bind to splice junctions and/or consensus sequence |
|
Regulators of splicing |
Exonic splicing enhancers (ESE), ST proteins, and cross-exon recognition complex |
|
Function of Exonic splicing enhancers |
Regulation of splicing |
|
Function of SR proteins |
Regulation of splicing |
|
Function of cross-exon recognition complex |
Regulation of splicing |
|
Function of PABPN1 |
Nuclear Poly(A)-binding protein, promotes fast polyadenylation |
|
Function of FG nucleoporins |
Barrier for diffusion of large macromolecules |
|
Processing of rRNA |
Trim larger rRNA down and methylate some nucleotides |
|
Processing of tRNA |
Trimming both ends of pre-tRNA, adding a CCA to the 3' end (site where amino acid is added), chemical modification of nucleotides, intron splicing |
|
Two regulations of transcription |
Chromatin condensation and transcriptional initiation |
|
Function of TFIIH |
Transcrtiption. Helicase and kinase (phos. the CTD of RNA Pol II) |
|
Function of SWI/SNF |
Chromatin remodeling. Slides DNA along nucleosomes or changes DNA conformation to expose regulatory regions |
|
Deamination |
Passive DNA demethylation |
|
Most common CF mutation |
F508 mutation |
|
Function of aminoacyl-tRNA synthetase |
Triggers tRNA linking to amino acid |
|
Function of Hsp (heat shock protein) |
Chaperone; stabilizes unfolded protein |
|
RNase + RNA-binding protein function |
Inactivates translation, promotes deadenylation |
|
Deamination of A to I causes what? |
I binds to C instead of U |
|
A to I editing of miRNAs results in? |
Can change target genes |
|
Function of XRN1 |
Endonuclease in RNA degradation |
|
Function of exosome |
Exonuclease in RNA degradation |
|
Function of eIF2 kinases |
Respond to environmental stress; in stress, phosporylates eIF2, inhibiting translation |